The threat of mosquito-borne arboviral disease in Spain: A bibliographic review

2022 ◽  
Author(s):  
Tanita Laycock ◽  
Clara Ureña Paniego ◽  
Jake Javier
Keyword(s):  
Arboviral Disease

scholarly journals Does Local Adaptation Impact on the Distribution of Competing Aedes Disease Vectors?

Climate ◽  
2021 ◽  
Vol 9 (2) ◽  
pp. 36
Author(s):  
Kelly L. Bennett ◽  
William Owen McMillan ◽  
Jose R. Loaiza
Keyword(s):  
Local Adaptation ◽  
Resource Competition ◽  
Disease Vectors ◽  
Human Populations ◽  
Transplant Experiment ◽  
Reciprocal Transplant Experiment ◽  
Climate Conditions ◽  
Ecological Resources ◽  
The Face ◽  
Arboviral Disease

Ae. (Stegomyia) aegypti L. and Aedes (Stegomyia) albopictus Skuse mosquitoes are major arboviral disease vectors in human populations. Interspecific competition between these species shapes their distribution and hence the incidence of disease. While Ae. albopictus is considered a superior competitor for ecological resources and displaces its contender Ae. aegypti from most environments, the latter is able to persist with Ae. albopictus under particular environmental conditions, suggesting species occurrence cannot be explained by resource competition alone. The environment is an important determinant of species displacement or coexistence, although the factors underpinning its role remain little understood. In addition, it has been found that Ae. aegypti can be adapted to the environment across a local scale. Based on data from the Neotropical country of Panama, we present the hypothesis that local adaptation to the environment is critical in determining the persistence of Ae. aegypti in the face of its direct competitor Ae. albopictus. We show that although Ae. albopictus has displaced Ae. aegypti in some areas of Panama, both species coexist across many areas, including regions where Ae. aegypti appear to be locally adapted to dry climate conditions and less vegetated environments. Based on these findings, we describe a reciprocal transplant experiment to test our hypothesis, with findings expected to provide fundamental insights into the role of environmental variation in shaping the landscape of emerging arboviral disease.

Improved detection of flaviviruses in Australian mosquito populations via replicative intermediates

2021 ◽  
Vol 102 (7) ◽  
Author(s):  
Caitlin A. O'Brien ◽  
Jessica J. Harrison ◽  
Agathe M. G. Colmant ◽  
Renee J. Traves ◽  
Devina Paramitha ◽  
...  
Keyword(s):  
Monoclonal Antibodies ◽  
Untranslated Regions ◽  
Fixation Method ◽  
Enveloped Viruses ◽  
Double Stranded Rna ◽  
Vertebrate Cell ◽  
Infected Cells ◽  
Replicative Intermediates ◽  
Dsrna Viruses ◽  
Arboviral Disease

Mosquito-borne flaviviruses are significant contributors to the arboviral disease burdens both in Australia and globally. While routine arbovirus surveillance remains a vital exercise to identify known flaviviruses in mosquito populations, novel or divergent and emerging species can be missed by these traditional methods. The MAVRIC (monoclonal antibodies to viral RNA intermediates in cells) system is an ELISA-based method for broad-spectrum isolation of positive-sense and double-stranded RNA (dsRNA) viruses based on detection of dsRNA in infected cells. While the MAVRIC ELISA has successfully been used to detect known and novel flaviviruses in Australian mosquitoes, we previously reported that dsRNA could not be detected in dengue virus-infected cells using this method. In this study we identified additional flaviviruses which evade detection of dsRNA by the MAVRIC ELISA. Utilising chimeric flaviviruses we demonstrated that this outcome may be dictated by the non-structural proteins and/or untranslated regions of the flaviviral genome. In addition, we report a modified fixation method that enables improved detection of flavivirus dsRNA and inactivation of non-enveloped viruses from mosquito populations using the MAVRIC system. This study demonstrates the utility of anti-dsRNA monoclonal antibodies for identifying viral replication in insect and vertebrate cell systems and highlights a unique characteristic of flavivirus replication.

scholarly journals Effect of Hurricane Katrina on Arboviral Disease Transmission

2007 ◽  
Vol 13 (8) ◽  
pp. 1273-1274 ◽  
Author(s):  
Jennifer A. Lehman ◽  
Alison F. Hinckley ◽  
Krista L. Kniss ◽  
Roger S. Nasci ◽  
Theresa L. Smith ◽  
...  
Keyword(s):  
Hurricane Katrina ◽  
Disease Transmission ◽  
Arboviral Disease

scholarly journals Boosting can explain patterns of fluctuations of ratios of inapparent to symptomatic dengue virus infections

2021 ◽  
Vol 118 (14) ◽  
pp. e2013941118
Author(s):  
Laura W. Alexander ◽  
Rotem Ben-Shachar ◽  
Leah C. Katzelnick ◽  
Guillermina Kuan ◽  
Angel Balmaseda ◽  
...  
Keyword(s):  
Dengue Virus ◽  
Denv Infection ◽  
Protective Effects ◽  
Virus Infections ◽  
Denv Serotypes ◽  
Symptomatic Disease ◽  
Large Fluctuations ◽  
Antibody Titers ◽  
Dengue Control ◽  
Arboviral Disease

Dengue is the most prevalent arboviral disease worldwide, and the four dengue virus (DENV) serotypes circulate endemically in many tropical and subtropical regions. Numerous studies have shown that the majority of DENV infections are inapparent, and that the ratio of inapparent to symptomatic infections (I/S) fluctuates substantially year-to-year. For example, in the ongoing Pediatric Dengue Cohort Study (PDCS) in Nicaragua, which was established in 2004, the I/S ratio has varied from 16.5:1 in 2006–2007 to 1.2:1 in 2009–2010. However, the mechanisms explaining these large fluctuations are not well understood. We hypothesized that in dengue-endemic areas, frequent boosting (i.e., exposures to DENV that do not lead to extensive viremia and result in a less than fourfold rise in antibody titers) of the immune response can be protective against symptomatic disease, and this can explain fluctuating I/S ratios. We formulate mechanistic epidemiologic models to examine the epidemiologic effects of protective homologous and heterologous boosting of the antibody response in preventing subsequent symptomatic DENV infection. We show that models that include frequent boosts that protect against symptomatic disease can recover the fluctuations in the I/S ratio that we observe, whereas a classic model without boosting cannot. Furthermore, we show that a boosting model can recover the inverse relationship between the number of symptomatic cases and the I/S ratio observed in the PDCS. These results highlight the importance of robust dengue control efforts, as intermediate dengue control may have the potential to decrease the protective effects of boosting.

scholarly journals Technical viability of the YF MAC-HD ELISA kit for use in yellow fever-endemic regions

2021 ◽  
Vol 15 (6) ◽  
pp. e0009417
Author(s):  
Christin H. Goodman ◽  
Maurice Demanou ◽  
Mick Mulders ◽  
Jairo Mendez-Rico ◽  
Alison Jane Basile
Keyword(s):  
South America ◽  
Yellow Fever ◽  
Accurate Diagnosis ◽  
Immunoglobulin M ◽  
Enzyme Linked Immunosorbent Assay ◽  
Elisa Kit ◽  
Wash Buffer ◽  
Antibody Capture ◽  
Vaccination Campaigns ◽  
Arboviral Disease

Yellow fever (YF), an arboviral disease, affects an estimated 200,000 people and causes 30,000 deaths per year and recently has caused major epidemics in Africa and South America. Timely and accurate diagnosis of YF is critical for managing outbreaks and implementing vaccination campaigns. A YF immunoglobulin M (IgM) antibody-capture (MAC) enzyme-linked immunosorbent assay (ELISA) kit, the YF MAC-HD, was successfully introduced starting in 2018 to laboratories in Africa and South America. The YF MAC-HD kit can be performed in 3.5 hours, test up to 24 samples, and includes all reagents necessary to perform the test, except for water used to dilute wash buffer. In 2018 and 2019, a total of 56 laboratory personnel from 39 countries in Africa and South America were trained to use the kit during workshops, followed by take-home YF IgM proficiency testing (PT) exercises. Participants received either a 10- or 20-sample YF PT panel and performed testing using the YF MAC-HD kit. All countries obtained 90% or higher correct results. These results verified the technical viability and transferability of YF MAC-HD kit use for laboratories in YF-endemic countries.

scholarly journals El Niño and arboviral disease prediction.

1999 ◽  
Vol 107 (10) ◽  
pp. 817-818 ◽  
Author(s):  
D Maelzer ◽  
S Hales ◽  
P Weinstein ◽  
M Zalucki ◽  
A Woodward
Keyword(s):  
El Niño ◽  
El Nino ◽  
Disease Prediction ◽  
Arboviral Disease

scholarly journals Assessing entomological risk factors for arboviral disease transmission in the French Territory of the Wallis and Futuna Islands

2020 ◽  
Vol 14 (5) ◽  
pp. e0008250
Author(s):  
Elodie Calvez ◽  
Nicolas Pocquet ◽  
Atoloto Malau ◽  
Sosiasi Kilama ◽  
Alefosio Taugamoa ◽  
...  
Keyword(s):  
Risk Factors ◽  
Disease Transmission ◽  
Arboviral Disease

scholarly journals Zika Virus Update: More on an Emerging Arboviral Disease in the Western Hemisphere

2016 ◽  
Vol 11 (2) ◽  
pp. 163-167 ◽  
Author(s):  
Kelly G. Vest
Keyword(s):  
Public Health ◽  
Zika Virus ◽  
Primary Care Providers ◽  
Western Hemisphere ◽  
Disease Spread ◽  
Care Providers ◽  
Neurologic Diseases ◽  
The Public ◽  
The World ◽  
Arboviral Disease

AbstractZika virus has captivated the world with its quick spread throughout the Western Hemisphere. Increased emphasis has been placed on the infection of pregnant women and subsequent adverse and severe effects in the developing fetus and newborn. This article supplements a previous article and provides updated information on new and evolving evidence that strengthens the association between Zika virus and unique congenital and neurologic diseases, updates what is known about the epidemiology of the disease, and provides new and updated material for primary care providers as they counsel patients who may be exposed or infected. With the extent of disease spread, it is expected that Zika virus will become endemic to the Western Hemisphere and will change the public health parameters and approach in this area of the world. (Disaster Med Public Health Preparedness. 2017;11:163–167)

West Nile Virus

2016 ◽  
Author(s):  
Matthew Finn
Keyword(s):  
West Nile Virus ◽  
Rna Virus ◽  
Immunoglobulin M ◽  
Enzyme Linked Immunosorbent Assay ◽  
Mosquito Vector ◽  
West Nile ◽  
Csf Analysis ◽  
Neuroinvasive Disease ◽  
Breeding Grounds ◽  
Arboviral Disease

West Nile virus (WNV) is a single-stranded RNA virus of the Flavivirus family that is transmitted via a mosquito vector, typically causing fever and capable of causing meningoencephalitis. Although mortality is low, it can lead to debilitating neuroinvasive disease in some patients. WNV is a leading cause of domestically-acquired arboviral disease and most commonly occurs in late August and early September. Consider WNV in otherwise unexplained cases of meningitis or encephalitis. Initial testing should consist of cerebrospinal fluid (CSF) analysis and West Nile immunoglobulin M enzyme-linked immunosorbent assay in serum and/or CSF. WNV is a nationally notifiable disease. Prevention remains the key to controlling this disease. Reducing the breeding grounds of the Culex mosquito and using insect repellant to prevent bites are two important strategies.

Sign in / Sign up

Export Citation Format

Share Document